(Q33483115)

English

A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design

scientific article published on 16 July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

0 references

object named as

Yann Le Strat

2

0 references

Jean-Claude Desenclos

11

object named as

Jean-Claude Desenclos

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

10

object named as

Francis Barin

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

4

object named as

Damien Thierry

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

author name string

Marie Jauffret-Roustide

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Elisabeth Couturier

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Marc Rondy

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Martine Quaglia

6

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Nicolas Razafandratsima

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Julien Emmanuelli

8

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Gaelle Guibert

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

16 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

BMC Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

113

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

16 July 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

The HCV Synthesis Project: scope, methodology, and preliminary results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Global estimates of prevalence of HCV infection among injecting drug users.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Impact of a harm-reduction policy on HIV and hepatitis C virus transmission among drug users: recent French data--the ANRS-Coquelicot Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Putting at risk what we know: reflecting on the drug-using subject in harm reduction and its political implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

HIV/hepatitis C virus co-infection in drug users: risk behavior and prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

A potential hidden source of hepatitis C infection among noninjecting drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Commentary: Modelling and understanding differences in human immunodeficiency and hepatitis C virus epidemiology in injection drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Risk factors for hepatitis C virus infection among street youths

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Gendered power dynamics and HIV risk in drug-using sexual relationships

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

HIV and hepatitis C among injecting drug users

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Epidemiology of hepatitis C virus infection among injecting drug users in Australia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Crack cocaine smoking and oral sores in three inner-city neighborhoods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Substance use and risky sexual behavior for exposure to HIV. Issues in methodology, interpretation, and prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

28 July 2018

Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Hepatitis C virus seroconversion among young injection drug users: relationships and risks

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Ethical issues in substance use intervention.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Preventing hepatitis C virus infection in injection drug users: risk reduction is not enough

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Review of sampling hard-to-reach and hidden populations for HIV surveillance

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

A short questionnaire (IRQ) to assess injecting risk behaviour.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Monitoring the Dynamics of the HIV Epidemic Using Assays for Recent Infection and Serotyping among New HIV Diagnoses: Experience after 2 Years in France

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Individual and couple-level risk factors for hepatitis C infection among heterosexual drug users: a multilevel dyadic analysis

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Factors associated with HIV/AIDS high-risk behaviours among female injection drug users.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-9-113

21 January 2018

Association between first injection risk behaviors and hepatitis C seropositivity among injecting drug users.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

31 October 2018

Single-room occupancy hotels: possible solutions and alternatives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

31 October 2018

Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2733898

31 October 2018

Sharing of drug preparation equipment as a risk factor for hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/19607712

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Crack users' cracked lips: an additional HIV risk factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19607712

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Life trajectory and risk-taking among women drug users]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19607712

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City

1 reference

https://pubmed.ncbi.nlm.nih.gov/19607712

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not

1 reference

https://pubmed.ncbi.nlm.nih.gov/19607712

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2334-9-113

1 reference

https://api.fatcat.wiki/v0/release/ebbcddmcvjaq5jhbohhherfsge

30 July 2022

based on heuristic

mapped directly with Wikidata item

Dimensions Publication ID

0 references

release_ebbcddmcvjaq5jhbohhherfsge

1 reference

https://api.fatcat.wiki/v0/release/ebbcddmcvjaq5jhbohhherfsge

30 July 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

https://api.fatcat.wiki/v0/release/ebbcddmcvjaq5jhbohhherfsge

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/ebbcddmcvjaq5jhbohhherfsge

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33483115&oldid=2195402867"